FimmCyte reposted this
FimmCyte, founded in 2022 as a spin-off of Universität Zürich, announces a CHF 1 Million funding from the UZH Life Sciences Fund. FimmCyte's most advanced program is a non-hormonal disease-modifying treatment for endometriosis. Congratulation to Valentina Vongrad❤️ and her Team! Happy Women's Day #IWD2024 https://lnkd.in/duanRdr8
Head UMZH Translational Medicine Accelerator
5moGreat to see how this project received such early and sustained support from the UZH ecosystem. This is how we make advancements towards patients that need it.